Philippine Daily Inquirer

GOING, GOING, GONE . . .

-

With the Supreme Court’s 2015 temporary restrainin­g order (TRO) on contracept­ive implants still in place, at least 459,294 units of Implanon and Implanon NXT are set to expire in 2018. This would mean squanderin­g some P261 million, the total cost of these contracept­ive supplies.

A contracept­ive implant is a small flexible tube, the size of a toothpick, placed subdermall­y in the upper arm. It releases progestero­ne hormone similar to the natural progestero­ne produced by women in their ovaries, which inhibits ovulation. The implant is highly effective up to three years.

Data from the Commission on Population show that with the expiration of the certificat­es of product registrati­on (CPR) of 42 contracept­ive brands between 2016 and 2018, about 90 percent of contracept­ive brands would no longer be available in the market by the end of 2018, unless new CPRs are issued by then.

Without new CPRs, the number of registered contracept­ive products available in the local market will go down from 32 this year, to 18 next year and 5 in 2019. By 2020, there will be zero contracept­ive brands with a CPR. ( See table for infographi­c). —ANAROA, INQUIRER RESEARCH Sources: Commission on Population, Inquirer Archives

Newspapers in English

Newspapers from Philippines